[SYRS] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
27-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -60.39%
YoY- -333.49%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 386 -5,467 7,802 5,699 508 893 0 -
PBT -64,384 -4,774 -23,813 -30,130 -19,729 -18,032 -15,302 27.04%
Tax 10,883 -32,349 986 1,417 0 0 -390 -
NP -64,384 27,575 -23,813 -30,130 -19,729 -18,032 -15,302 27.04%
Tax Rate - - - - - - - -
Total Cost 64,770 -33,042 31,615 35,829 20,237 18,925 15,302 27.17%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -16,679.79 -504.39 -305.22 -528.69 -3,883.66 -2,019.26 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -2.18 0.99 -3.78 -4.91 -4.60 -5.35 -5.81 -15.06%
EPS Diluted -2.18 0.99 -3.78 -4.91 -4.49 -5.34 -5.81 -15.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.